Table 2.
Complications noted and use of antibiotics in influenza-infected patients
| Trial | Southern Hemisphere (NAIB3001) | Europe (NAIB3002) | North America (NAIA3002) |
|---|---|---|---|
| Complications | |||
| Placebo | 30% | 33% | 22% |
| Zanamivir | 24% | 24% | 15% |
| P value | 0.24 | 0.125 | 0.049* |
| Antibiotics use | |||
| Placebo | 28% | 17% | 15% |
| Zanamivir | 26% | 11% | 11% |
| P value | 0.58 | 0.21 | 0.16 |
*P < 0.05